The U.S. Food and Drug Administration (FDA) has accepted for review Biologics License Applications (BLA) for AVT05, ...

ThinkCyte, a biotechnology company pioneering novel artificial intelligence (AI)-based cell analysis and sorting instruments, ...

The supplemental new drug application is based on data from the Phase 2 LITESPARK-015 trial.

Touchlight, a leader in synthetic DNA technology, has appointed Will Downie as a key adviser to support its mission of ...

Clinigen, a global specialist pharmaceutical services company, entered a strategic partnership with Tepsivo, a digital Pharmacovigilance (PV) services provider. As part of the partnership, Clinigen ...

ReiThera has inked a comprehensive Master Service Agreement (MSA) with SillaJen, which establishes ReiThera as the ...

The approval was based on results from the TROPION-Breast01 Phase III trial.

As Bora Biologics, the organization will continue to build upon its established reputation for quality and excellence in ...

Since its creation by a team of pharmaceutical, cold-chain management and quality assurance experts in 2004, Sentry BioPharma ...

Neurocrine Biosciences Inc. has appointed Andrew Ratz, Ph.D. as Senior Vice President of Drug Development, Delivery and ...

The goal is to treat familial dysautonomia patients with a single injection.

Kincell Bio, a cell therapy development and manufacturing organization (CDMO), has appointed Mark R. Bamforth as Chief ...